Phosphole derivatives complexed with metals, and pharmaceutical uses thereof
Référence
86508-01
Mots-clés
Statut des brevets
French patent application FR0408427 filed on July 20th, 2004 and entitled “Dérivés phospholes complexés à des métaux et leurs utilisations pharmaceutiques”.
Inventeurs
Elisabeth DAVIOU-CHARVET
Katja BECLER-BRANDENBURG
Valérie DEBORDE
Régis REAU
Heiner SCHIRMER
Christel HEROLD-MENDE
Statut commercial
Exclusive or non-exclusive licenses
Laboratoire
Interdisciplinary Research Center, Giessen University, Germany
Biochemie-Zentrum, Heidelberg University, Germany
Department of Neurosurgery, Heidelberg University, Germany
UMR 6509, CNRS / Rennes 1 University, France.
Description
TECHNICAL DESCRIPTION
This invention describes pharmaceutical compositions containing phosphole derivatives complexed with gold or platinium and their use in particular for the prevention or treatment of pathologies associated with an excess activity of human glutathione reductase and/or thioredoxin reductase. These components act as irreversible inhibitors of glutathione and thioredoxin reductases.
INDUSTRIAL APPLICATIONS
– Prevention or treatment of cancers, rheumatoid polyarthritis, psoriasis or Sögren syndrome.
– Prevention or treatment of resistance to anti-cancerous drugs.
The anti-tumour activity of this pharmaceutical composition was tested in vivo on rat and showed a 44% reduction of the tumour size.
For further information, please contact us (Ref 86508-01)
Besoin de plus d'informations ?
Nous contacterTechnologies Liées
-
31.03.2015
Protein involved in DNA replication, and modulation of its activity
Health / Therapeutic, Medical Diagnostic 06081-01
-
10.03.2014
Protein complex mcm8/mcm9, inhibitors thereof, and their use for enhancing or reducing animal fertility
Health / Therapeutic, Other Technologies 00017-04
-
03.03.2014
Chimeric molecule involving oligomerized FasL extracellular domain
Health / Therapeutic 03946-01